Incidentalome
|
WikiDoc Resources for Incidentalome |
|
Articles |
|---|
|
Most recent articles on Incidentalome Most cited articles on Incidentalome |
|
Media |
|
Powerpoint slides on Incidentalome |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Incidentalome at Clinical Trials.gov Trial results on Incidentalome Clinical Trials on Incidentalome at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Incidentalome NICE Guidance on Incidentalome
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Incidentalome Discussion groups on Incidentalome Patient Handouts on Incidentalome Directions to Hospitals Treating Incidentalome Risk calculators and risk factors for Incidentalome
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Incidentalome |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Overview
The incidentalome is the phenomenon of all possible incidental findings.The term was coined as an extension of incidentaloma which refers to the incidental, often radiographic findings of masses or tumors whose significance and prognosis is therefore poorly understood. In the genomic era, the lack of prior probabilities regarding the clinical import of each genetic variant creates the likelihood of a large proportion of false positives, if genetic testing is not placed on a systematic quantitative basis.
"If practitioners pursue unexpected genomic findings without thought, there may be untoward consequences. Specifically, physicians will be overwhelmed by the complexity of pursuing unexpected genomic measurements, patients will be subject to unnecessary follow-up tests, causing additional morbidity, and the cost of genomic medicine will increase substantially with little benefit to patients or physicians, thus casting into question the benefit of genomic-based medicine." [1]
The incidentalome raises a challenge for both the FDA approval of panels (e.g. SNP chips) [2] of genetic tests as well as the substance of medical education in the genomic era.